C82.37

Clinical Causes: Genetic mutations: Changes in specific genes can lead to abnormal cell growth. Age: Most cases are diagnosed in middle-aged to older adults. Immune system factors: Weakened immune defenses may influence the development. History of other lymphatic diseases: Previous lymphomas or autoimmune conditions may increase risk. Environmental exposures: Certain chemicals and radiation exposure might contribute, though definitive links are still under research.

Key Symptoms: Swelling in the abdomen or chest due to enlarged spleen Feeling of fullness after eating small amounts Unexplained weight loss Persistent fatigue or weakness Fever or night sweats Frequent infections due to compromised immune function Pain or discomfort in the left upper abdomen

Diagnosis Path: Physical examination to detect spleen enlargement Blood tests to assess blood cell counts and overall health Imaging studies such as ultrasound, CT scans, or PET scans to visualize spleen size and detect other affected areas Lymph node biopsy or spleen biopsy to examine tissue microscopically and identify characteristic lymphoma cells Bone marrow aspiration may also be performed to evaluate the extent of disease spread

Treatment Protocols: Chemotherapy: Use of drugs to kill or slow the growth of cancer cells Immunotherapy: Medications that help the immune system recognize and attack lymphoma cells, such as monoclonal antibodies Targeted therapy: Drugs aimed specifically at molecular targets involved in the cancer's growth Radiation therapy: Focused radiation to eliminate localized disease, often used when there is spleen or lymph node involvement Watchful waiting: In some cases with slow progression, active monitoring without immediate treatment may be recommended Stem cell transplantation: For eligible patients, to help rebuild healthy blood cells after intensive therapy